These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8712274)

  • 1. State tobacco lobbyists and organizations in the United States: crossed lines.
    Goldstein AO; Bearman NS
    Am J Public Health; 1996 Aug; 86(8):1137-42. PubMed ID: 8712274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State legislators' perceptions of lobbyists and lobbying on tobacco control issues.
    Cohen JE; Goldstein AO; Flynn BS; Munger MC; Gottlieb NH; Solomon LJ; Dana GS
    Tob Control; 1997; 6(4):332-6. PubMed ID: 9583632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How tobacco companies use the revolving door between government and industry to influence policymaking: an Australian case study.
    Watts C; Jones M; Lindorff K; Freeman B
    Public Health Res Pract; 2023 Dec; 33(4):. PubMed ID: 37164761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010-2021.
    Rotering T; Apollonio DE
    Int J Drug Policy; 2022 Apr; 102():103585. PubMed ID: 35085854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the Lobbying Footprint of Harmful Industries: 23 Years of Data From OpenSecrets.
    Chung H; Cullerton K; Lacy-Nichols J
    Milbank Q; 2024 Mar; 102(1):212-232. PubMed ID: 38219274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can lobbyists represent tobacco and health?
    Pallarito K
    Mod Healthc; 1993 Mar; 23(12):20. PubMed ID: 10124742
    [No Abstract]   [Full Text] [Related]  

  • 7. Tobacco Industry Influences in the Oklahoma Legislature.
    Matheny JD; Wagener TL; Anderson MP
    J Okla State Med Assoc; 2015 Nov; 108(11):441-9. PubMed ID: 26817060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobbying by omission: what is known and unknown about harmful industry lobbyists in Australia.
    Lacy-Nichols J; Christie S; Cullerton K
    Health Promot Int; 2023 Oct; 38(5):. PubMed ID: 37864804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018.
    Wouters OJ
    JAMA Intern Med; 2020 May; 180(5):688-697. PubMed ID: 32125357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco Institute lobbying at the state and local levels of government in the 1990s.
    Morley CP; Cummings KM; Hyland A; Giovino GA; Horan JK
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I102-9. PubMed ID: 11893820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care lobbying in the United States.
    Landers SH; Sehgal AR
    Am J Med; 2004 Apr; 116(7):474-7. PubMed ID: 15047037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do physicians lobby their members of Congress?
    Landers SH; Sehgal AR
    Arch Intern Med; 2000 Nov; 160(21):3248-51. PubMed ID: 11088085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
    Muggli ME; Hurt RD; Becker LB
    Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interest Group Conflict Over Medicaid Expansion: The Surprising Impact of Public Advocates.
    Callaghan T; Jacobs LR
    Am J Public Health; 2016 Feb; 106(2):308-13. PubMed ID: 26691109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco industry allegations of "illegal lobbying" and state tobacco control.
    Bialous SA; Fox BJ; Glantz SA
    Am J Public Health; 2001 Jan; 91(1):62-7. PubMed ID: 11189827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco lobby political influence on US state legislatures in the 1990s.
    Givel MS; Glantz SA
    Tob Control; 2001 Jun; 10(2):124-34. PubMed ID: 11387532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dear health care lobbyists . .
    Sharfstein JM
    Milbank Q; 2015 Mar; 93(1):15-8. PubMed ID: 25752344
    [No Abstract]   [Full Text] [Related]  

  • 18. Lobbyists on guard in midst of chaos.
    Ortolon K
    Tex Med; 1989 Jun; 85(6):25-9. PubMed ID: 2734709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new attack on smoking using an old-time remedy.
    Moore MC; Mikhail CJ
    Public Health Rep; 1996; 111(3):192-203. PubMed ID: 8643810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco industry lobbyists and their health-care clients.
    Hopkinson NS; Moxham J; Montgomery H; West R; Scally G; McKee M; Spiro S; Bush A; Stradling J; Wells A; Chung KF; Durham SR; Martin FC; Congleton J; Roddy E; Dayer M; White P; Ind PW; Brown JL; Patel I; Lewis K; Hart N; Kemp S; Barker J; Hind M; Nicholl D; Stern M; Elkin S
    Lancet; 2013 Feb; 381(9865):445. PubMed ID: 23399061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.